Acamprosate for alcohol use disorder
https://libcat.nshealth.ca/en/permalink/chpams37562
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 2268
- Available Online
- View Pamphlet
Acamprosate is a medication used to help manage alcohol dependence. It works best for people who would like to stop drinking alcohol fully, not just drink less. This pamphlet explains how to take this medication, whether acamprosate interacts with other medications, what will happen if you drink alcohol while taking acamprosate, how long you will need to take acamprosate, possible side effects, and how much acamprosate costs.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([2] p.) : digital, PDF file
- Subjects (MeSH)
- Acamprosate
- Alcohol-Related Disorders - therapy
- Alcoholism - drug therapy
- Subjects (LCSH)
- Acamprosate
- Alcoholism--Treatment
- Specialty
- Medications
- Abstract
- Acamprosate is a medication used to help manage alcohol dependence. It works best for people who would like to stop drinking alcohol fully, not just drink less. This pamphlet explains how to take this medication, whether acamprosate interacts with other medications, what will happen if you drink alcohol while taking acamprosate, how long you will need to take acamprosate, possible side effects, and how much acamprosate costs.
- Notes
- Previous title: Acamprosate for alcohol dependence
- Responsibility
- Prepared by: Pharmacy Services, Aberdeen Hospital
- Pamphlet Number
- 2268
Adalimumab therapy for inflammatory bowel disease (IBD)
https://libcat.nshealth.ca/en/permalink/chpams35127
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 1207
- Available Online
- View Pamphlet
Your health care provider feels that treatment with adalimumab may help you manage your inflammatory bowel disease (IBD). This pamphlet describes what adalimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (11 p.) : digital, PDF file
- Subjects (MeSH)
- Adalimumab
- Inflammatory Bowel Diseases - drug therapy
- Subjects (LCSH)
- Inflammatory bowel diseases
- Specialty
- Medications
- Abstract
- Your health care provider feels that treatment with adalimumab may help you manage your inflammatory bowel disease (IBD). This pamphlet describes what adalimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
- Notes
- Previous title: Adalimumab (Humira) therapy
- Responsibility
- Prepared by: Nova Scotia Collaborative IBD Program
- Pamphlet Number
- 1207
Aripiprazole (Abilify, Abilify Maintena)
https://libcat.nshealth.ca/en/permalink/chpams35626
Nova Scotia Health Authority. Pharmacy Services.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 1627
- Available Online
- View Pamphlet
Aripiprazole is most often used to treat psychosis. It is also used to treat mania and sometimes depression. This pamphlet explains how to take aripiprazole, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Pharmacy Services
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([2] p.) : digital, PDF file
- Subjects (MeSH)
- Aripiprazole
- Subjects (LCSH)
- Antipsychotic drugs
- Specialty
- Medications
- Abstract
- Aripiprazole is most often used to treat psychosis. It is also used to treat mania and sometimes depression. This pamphlet explains how to take aripiprazole, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
- Responsibility
- Prepared by: Pharmacy Services
- Pamphlet Number
- 1627
Nova Scotia Health Authority. QEII. Pharmacy Department.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 0071
- Available Online
- View Pamphlet
The pamphlet explains what Aspirin® is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medications and foods to avoid. Symptoms that would need to be checked in the Emergency Department are also listed.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. QEII. Pharmacy Department
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (5 p.) : digital, PDF file
- Subjects (MeSH)
- Aspirin
- Subjects (LCSH)
- Aspirin
- Specialty
- Medications
- Abstract
- The pamphlet explains what Aspirin® is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medications and foods to avoid. Symptoms that would need to be checked in the Emergency Department are also listed.
- Responsibility
- Prepared by: Pharmacy Department
- Pamphlet Number
- 0071
Azathioprine and Mercaptopurine Therapy
https://libcat.nshealth.ca/en/permalink/chpams35565
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program.
Halifax, NS:
Nova Scotia Health Authority
, 2021.
- Pamphlet Number
- 1079
- Available Online
- View Pamphlet
This pamphlet will help you decide if azathioprine (Imuran®) or mercaptopurine therapy is right for you. The pamphlet explains what azathioprine (AZA) and mercaptopurine (6-MP) are, how well they work, as well as serious and less serious side-effects. The pamphlet also includes a list of what you can do to lower the chances of side-effects.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2021
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (6 p.): digital, PDF file
- Subjects (MeSH)
- Immunosuppressive Agents
- Azathioprine
- Mercaptopurine
- Subjects (LCSH)
- Immunosuppressive agents
- Specialty
- Medications
- Abstract
- This pamphlet will help you decide if azathioprine (Imuran®) or mercaptopurine therapy is right for you. The pamphlet explains what azathioprine (AZA) and mercaptopurine (6-MP) are, how well they work, as well as serious and less serious side-effects. The pamphlet also includes a list of what you can do to lower the chances of side-effects.
- Notes
- Previous title: Azathioprine (Imuran) therapy
- Responsibility
- Prepared by: Nova Scotia Collaborative Inflammatory Bowel Disease Program
- Pamphlet Number
- 1079
Benzodiazepines for alcohol withdrawal
https://libcat.nshealth.ca/en/permalink/chpams37554
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 2262
- Available Online
- View Pamphlet
Benzodiazepines are a group of medications that work as sedatives. They are commonly called “benzos”. Diazepam and lorazepam are 2 benzodiazepines used to manage all stages of alcohol withdrawal. This pamphlet explains how to take this medication, how benzodiazepines help, how your prescriber will decide which benzodiazepine is right for you, how much medication you will need, and possible side effects.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([2] p.) : digital, PDF file
- Subjects (LCSH)
- Benzodiazepines
- Alcoholism--Treatment
- Specialty
- Medications
- Abstract
- Benzodiazepines are a group of medications that work as sedatives. They are commonly called “benzos”. Diazepam and lorazepam are 2 benzodiazepines used to manage all stages of alcohol withdrawal. This pamphlet explains how to take this medication, how benzodiazepines help, how your prescriber will decide which benzodiazepine is right for you, how much medication you will need, and possible side effects.
- Responsibility
- Prepared by: Pharmacy Services, Aberdeen Hospital
- Pamphlet Number
- 2262
Bowel preparation for chronic kidney disease before colonoscopy
https://libcat.nshealth.ca/en/permalink/chpams35387
Nova Scotia Health Authority. Renal Program, Nova Scotia Health Authority. Pharmacy Services.
Halifax, NS:
Nova Scotia Health Authority
, 2020.
- Pamphlet Number
- 1475
- Available Online
- View Pamphlet
This pamphlet describes how to get ready for a colonoscopy if you have chronic kidney disease. Steps to prepare solutions on the day before your colonoscopy are listed. The day before your procedure and on the day of the test you should drink only clear liquids, and a suggested list is included. Remember not to eat any food or drink milk, or other liquids that are not clear, on the day before your colonoscopy or on the day of the test.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Nova Scotia Health Authority. Pharmacy Services
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2020
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (5 p.) : digital, PDF file
- Subjects (MeSH)
- Cathartics
- Colonoscopy
- Renal Insufficiency, Chronic
- Subjects (LCSH)
- Laxatives
- Colonoscopy
- Chronic renal failure
- Specialty
- Medications
- Nephrology
- Abstract
- This pamphlet describes how to get ready for a colonoscopy if you have chronic kidney disease. Steps to prepare solutions on the day before your colonoscopy are listed. The day before your procedure and on the day of the test you should drink only clear liquids, and a suggested list is included. Remember not to eat any food or drink milk, or other liquids that are not clear, on the day before your colonoscopy or on the day of the test.
- Responsibility
- Prepared by: NSHA Renal Program Educators and Pharmacists
- Pamphlet Number
- 1475
Buprenorphine for opioid use disorder
https://libcat.nshealth.ca/en/permalink/chpams37561
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 2267
- Available Online
- View Pamphlet
Buprenorphine is a medication used to treat opioid use disorder. It is long-acting, which means it is slowly released in the body over a longer time. This pamphlet explains how to take this medication, how fast buprenorphine starts to work, how your health care team will find the right dose for you, and how long you will need to take buprenorphine. Information on whether buprenorphine interacts with any other medications and possible side effects is included.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Buprenorphine
- Opioid-Related Disorders - therapy
- Subjects (LCSH)
- Buprenorphine
- Opioid abuse
- Specialty
- Medications
- Abstract
- Buprenorphine is a medication used to treat opioid use disorder. It is long-acting, which means it is slowly released in the body over a longer time. This pamphlet explains how to take this medication, how fast buprenorphine starts to work, how your health care team will find the right dose for you, and how long you will need to take buprenorphine. Information on whether buprenorphine interacts with any other medications and possible side effects is included.
- Responsibility
- Prepared by: Pharmacy Services, Aberdeen Hospital
- Pamphlet Number
- 2267
Nova Scotia Health Authority. QEII. Pharmacy Department.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 0249
- Available Online
- View Pamphlet
This pamphlet explains what clopidogrel is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medications and foods to avoid. Symptoms that would need to be checked in the Emergency Department are listed.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. QEII. Pharmacy Department
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (4 p.) : digital, PDF file
- Subjects (MeSH)
- Anticoagulants
- Subjects (LCSH)
- Anticoagulants (Medicine)
- Specialty
- Medications
- Abstract
- This pamphlet explains what clopidogrel is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medications and foods to avoid. Symptoms that would need to be checked in the Emergency Department are listed.
- Responsibility
- Prepared by: Pharmacy Department
- Pamphlet Number
- 0249
Corticosteroid therapy in inflammatory bowel disease (IBD)
https://libcat.nshealth.ca/en/permalink/chpams35480
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program.
Halifax, NS:
Nova Scotia Health Authority
, 2021.
- Pamphlet Number
- 1546
- Available Online
- View Pamphlet
Corticosteroids (kor-ti-koh-STER-oids) are strong inhibitors of inflammation (swelling). To ‘inhibit’ means to slow down or cut down on something. This pamphlet explains what corticosteriods do, how they work, when they are used, and how they are given. Precautions, side effects, and what to expect after treatment are explained. Side effects that require contacting your primary health care provider are listed.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program
- Alternate Title
- Corticosteroid therapy in IBD
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2021
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (9 p.) : digital, PDF file
- Subjects (MeSH)
- Inflammatory Bowel Diseases - drug therapy
- Prednisone
- Subjects (LCSH)
- Inflammatory bowel diseases
- Prednisone
- Specialty
- Gastrointestinal System
- Medications
- Abstract
- Corticosteroids (kor-ti-koh-STER-oids) are strong inhibitors of inflammation (swelling). To ‘inhibit’ means to slow down or cut down on something. This pamphlet explains what corticosteriods do, how they work, when they are used, and how they are given. Precautions, side effects, and what to expect after treatment are explained. Side effects that require contacting your primary health care provider are listed.
- Notes
- This pamphlet replaced pamphlet 1139, Prednisone Therapy.
- Responsibility
- Prepared by: Nova Scotia Collaborative Inflammatory Bowel Disease Program
- Pamphlet Number
- 1546
Cytomegalovirus (CMV)
https://libcat.nshealth.ca/en/permalink/chpams36606
Nova Scotia Health Authority. Kidney Transplant Clinic.
Halifax, NS:
Nova Scotia Health Authority
, 2019.
- Pamphlet Number
- 1999
- Available Online
- View Pamphlet
The cytomegalovirus (CMV) is a common virus found in people of all ages. People who have had a kidney transplant and are taking immunosuppressive medications are at risk. The pamphlet outlines the symptoms, how the virus is diagnosed, and how it is treated.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Kidney Transplant Clinic
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2019
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([1] p.) : digital, PDF file
- Subjects (MeSH)
- Cytomegalovirus
- Kidney Transplantation - adverse effects
- Immunosuppressive Agents - adverse effects
- Specialty
- Nephrology
- Medications
- Abstract
- The cytomegalovirus (CMV) is a common virus found in people of all ages. People who have had a kidney transplant and are taking immunosuppressive medications are at risk. The pamphlet outlines the symptoms, how the virus is diagnosed, and how it is treated.
- Responsibility
- Prepared by: Kidney Transplant Clinic
- Pamphlet Number
- 1999
Cytotoxic precautions at home
https://libcat.nshealth.ca/en/permalink/chpams37335
Nova Scotia Health. Nova Scotia Cell Therapy and Transplant Program.
Halifax, NS:
Nova Scotia Health Cancer Care Program
, 2022.
- Pamphlet Number
- 4037
- Available Online
- View Pamphlet
You are being treated with a cancer treatment that is cytotoxic. This means it can kill cancer cells and can harm healthy cells. This booklet describes what you, your family, friends and caregivers need to know about cytotoxic precautions. These precautions are used to keep your family members, friends and caregivers safe while you are taking your cancer treatment. This pamphlet explains what cytotoxic precautions are, what body fluids are cytotoxic, how to handle your body wastes, what to do …
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health. Nova Scotia Cell Therapy and Transplant Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Cancer Care Program
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (5 p.) : digital, PDF file
- Subjects (MeSH)
- Neoplasms - drug therapy
- Patient Safety
- Cytotoxins--toxicity
- Subjects (LCSH)
- Cancer--Chemotherapy
- Patient safety
- Specialty
- Cancer Care
- Medications
- Abstract
- You are being treated with a cancer treatment that is cytotoxic. This means it can kill cancer cells and can harm healthy cells. This booklet describes what you, your family, friends and caregivers need to know about cytotoxic precautions. These precautions are used to keep your family members, friends and caregivers safe while you are taking your cancer treatment. This pamphlet explains what cytotoxic precautions are, what body fluids are cytotoxic, how to handle your body wastes, what to do if your body wastes spill and what to do with the garbage. Information about dishes, laundry, sex, having a baby, breastfeeding, and how to bring samples to the hospital is included.
- Responsibility
- Prepared by: Nova Scotia Cell Therapy and Transplant Program
- Pamphlet Number
- 4037
Disulfiram for alcohol dependence
https://libcat.nshealth.ca/en/permalink/chpams37563
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 2269
- Available Online
- View Pamphlet
Disulfiram is a medication used to help manage alcohol dependence. It works best for people who would like to stop drinking alcohol completely, not just drink less. This pamphlet explains how to take this medication, what will happen if you drink alcohol while taking disulfiram, how well disulfiram works, whether disulfiram interacts with other medications or foods, and how long you will need to take this medication. Possible side effects are included.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([2] p.) : digital, PDF file
- Subjects (MeSH)
- Disulfiram
- Alcohol-Related Disorders - therapy
- Alcoholism - drug therapy
- Subjects (LCSH)
- Disulfiram
- Alcoholism--Treatment
- Specialty
- Medications
- Abstract
- Disulfiram is a medication used to help manage alcohol dependence. It works best for people who would like to stop drinking alcohol completely, not just drink less. This pamphlet explains how to take this medication, what will happen if you drink alcohol while taking disulfiram, how well disulfiram works, whether disulfiram interacts with other medications or foods, and how long you will need to take this medication. Possible side effects are included.
- Responsibility
- Prepared by: Pharmacy Services, Aberdeen Hospital
- Pamphlet Number
- 2269
Golimumab (Simponi®) for inflammatory bowel disease (IBD)
https://libcat.nshealth.ca/en/permalink/chpams35651
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 1641
- Available Online
- View Pamphlet
Your health care provider feels that treatment with golimumab may help you manage your inflammatory bowel disease (IBD). This pamphlet describes what golimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (12 p.) : digital, PDF file
- Subjects (MeSH)
- Golimumab
- Inflammatory Bowel Diseases - drug therapy
- Subjects (LCSH)
- Inflammatory bowel diseases
- Specialty
- Medications
- Abstract
- Your health care provider feels that treatment with golimumab may help you manage your inflammatory bowel disease (IBD). This pamphlet describes what golimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
- Notes
- Previous title: Golimumab (Simponi) therapy
- Responsibility
- Prepared by: Nova Scotia Collaborative IBD Program
- Pamphlet Number
- 1641
Methadone for opioid use disorder
https://libcat.nshealth.ca/en/permalink/chpams37548
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 2259
- Available Online
- View Pamphlet
Methadone is a medication used to treat opioid use disorder. It is long-acting, which means it is slowly released in the body over a long time. This pamphlet explains how to take this medication, how fast methadone starts to work, how your health care team will find the right dose for you, and how long you will need to take methadone. Information about interactions with other medications and possible side effects is included.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([2] p.) : digital, PDF file
- Subjects (MeSH)
- Methadone
- Subjects (LCSH)
- Methadone hydrochloride
- Specialty
- Medications
- Abstract
- Methadone is a medication used to treat opioid use disorder. It is long-acting, which means it is slowly released in the body over a long time. This pamphlet explains how to take this medication, how fast methadone starts to work, how your health care team will find the right dose for you, and how long you will need to take methadone. Information about interactions with other medications and possible side effects is included.
- Responsibility
- Prepared by: Pharmacy Services, Aberdeen Hospital
- Pamphlet Number
- 2259
Methotrexate (MTX) therapy for inflammatory bowel disease (IBD)
https://libcat.nshealth.ca/en/permalink/chpams34942
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program.
Halifax, NS:
Nova Scotia Health Authority
, 2021.
- Pamphlet Number
- 1138
- Available Online
- View Pamphlet
Your health care provider feels that treatment with methotrexate (meth-oh-TREX-ate) might help your Crohn’s disease or ulcerative colitis. These are both types of inflammatory bowel disease (IBD). This pamphlet explains what methotrexate (MTX) is, how well it works, side effects of MTX, who should not take MTX, and precautions. Instructions for injecting MTX are given.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2021
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (13 p.) : digital, PDF file
- Specialty
- Gastrointestinal System
- Medications
- Abstract
- Your health care provider feels that treatment with methotrexate (meth-oh-TREX-ate) might help your Crohn’s disease or ulcerative colitis. These are both types of inflammatory bowel disease (IBD). This pamphlet explains what methotrexate (MTX) is, how well it works, side effects of MTX, who should not take MTX, and precautions. Instructions for injecting MTX are given.
- Responsibility
- Prepared by: Nova Scotia Collaborative Inflammatory Bowel Disease Program
- Pamphlet Number
- 1138
Naltrexone for alcohol use disorder
https://libcat.nshealth.ca/en/permalink/chpams37555
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 2263
- Available Online
- View Pamphlet
Naltrexone is a medication used to help manage alcohol dependence. This medication works on the reward pathways in the brain by lowering the good feeling you get from drinking alcohol. Naltrexone may help you drink less. This pamphlet explains how to take this medication, how well naltrexone works, whether naltrexone interacts with other medications, what will happen if you drink alcohol while taking naltrexone, how long you will need to take naltrexone, possible side effects, and how much nalt…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([2] p.) : digital, PDF file
- Subjects (MeSH)
- Naltrexone
- Alcohol-Related Disorders - therapy
- Alcoholism - drug therapy
- Subjects (LCSH)
- Naltrexone
- Alcoholism--Treatment
- Specialty
- Medications
- Abstract
- Naltrexone is a medication used to help manage alcohol dependence. This medication works on the reward pathways in the brain by lowering the good feeling you get from drinking alcohol. Naltrexone may help you drink less. This pamphlet explains how to take this medication, how well naltrexone works, whether naltrexone interacts with other medications, what will happen if you drink alcohol while taking naltrexone, how long you will need to take naltrexone, possible side effects, and how much naltrexone costs.
- Notes
- Previous title: Naltrexone for alcohol dependence
- Responsibility
- Prepared by: Pharmacy Services, Aberdeen Hospital
- Pamphlet Number
- 2263
Olanzapine (Zyprexa, Zyprexa Zydis)
https://libcat.nshealth.ca/en/permalink/chpams35690
Nova Scotia Health Authority. Pharmacy Services.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 1669
- Available Online
- View Pamphlet
Olanzapine is most often used to treat psychosis or mania. This pamphlet explains how to take olanzapine, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Pharmacy Services
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([2] p.) : digital, PDF file
- Subjects (LCSH)
- Antipsychotic drugs
- Manic-depressive illness
- Schizophrenia--Treatment
- Specialty
- Medications
- Abstract
- Olanzapine is most often used to treat psychosis or mania. This pamphlet explains how to take olanzapine, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
- Responsibility
- Prepared by: Pharmacy Services
- Pamphlet Number
- 1669
Nova Scotia Health Authority. CVAD Practice Committee.
Halifax, NS:
Nova Scotia Health Authority
, 2021.
- Pamphlet Number
- 1571
- Available Online
- View Pamphlet
A PICC (Peripherally Inserted Central Catheter) line is a long intravenous (IV) catheter (tube). This IV is placed into a large vein in your arm and threaded into a large vein just above your heart. You may need a PICC line for long-term IV therapy of fluids and medication(s). This pamphlet explains the benefits of having a PICC line, where to go to get a PICC line, how your PICC line will be put in, what will happen after the procedure, the risks of inserting and having a PICC line, and care o…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. CVAD Practice Committee
- Alternate Title
- Peripherally inserted central catheter line
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2021
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (10 p.) : digital, PDF file
- Subjects (MeSH)
- Catheterization, Peripheral
- Medications
- Subjects (LCSH)
- Catheterization
- Drugs
- Specialty
- Medications
- Abstract
- A PICC (Peripherally Inserted Central Catheter) line is a long intravenous (IV) catheter (tube). This IV is placed into a large vein in your arm and threaded into a large vein just above your heart. You may need a PICC line for long-term IV therapy of fluids and medication(s). This pamphlet explains the benefits of having a PICC line, where to go to get a PICC line, how your PICC line will be put in, what will happen after the procedure, the risks of inserting and having a PICC line, and care of your PICC line. Symptoms that require you to contact your primary health care provider or call 911 are listed. What to do if the PICC line breaks or is damaged is also included.
- Responsibility
- Prepared by: CVAD Practice Committee
- Pamphlet Number
- 1571
Polyoma virus and BK virus
https://libcat.nshealth.ca/en/permalink/chpams35425
Nova Scotia Health Authority. Kidney Transplant Clinic.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 1510
- Available Online
- View Pamphlet
BK virus is a part of the polyoma virus family. About 80% of people carry the virus. People usually get this virus as children. It can stay inactive in your body without causing harm for many years. It can become active if you are immunocompromised (your immune system is weak). People who have had a kidney transplant and are taking immunosuppressive medications (medications that suppress [lower] your immune system) are at risk of infection from the virus. This pamphlet explains the symptoms of …
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Kidney Transplant Clinic
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Polyomavirus
- BK Virus
- Kidney Transplantation - adverse effects
- Immunosuppressive Agents - adverse effects
- Subjects (LCSH)
- Polyomaviruses
- Kidneys--Transplantation
- Immunosuppressive agents
- Specialty
- Nephrology
- Medications
- Abstract
- BK virus is a part of the polyoma virus family. About 80% of people carry the virus. People usually get this virus as children. It can stay inactive in your body without causing harm for many years. It can become active if you are immunocompromised (your immune system is weak). People who have had a kidney transplant and are taking immunosuppressive medications (medications that suppress [lower] your immune system) are at risk of infection from the virus. This pamphlet explains the symptoms of BK virus, how BK virus is diagnosed, and how it is treated.
- Responsibility
- Prepared by: Kidney Transplant Clinic
- Pamphlet Number
- 1510
